MARKET

IHE

IHE

iShares US Pharmaceuticals ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

187.79
+2.51
+1.35%
Closed 16:00 09/23 EDT
OPEN
186.26
PREV CLOSE
185.28
HIGH
188.34
LOW
186.26
VOLUME
5
TURNOVER
--
52 WEEK HIGH
199.51
52 WEEK LOW
157.93
TOTAL ASSET
395.96M
YTD YIELD
3.26%
1D
5D
1M
3M
1Y
5Y
J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data
Zacks.com · 1d ago
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
Zacks.com · 1d ago
ETF Weekender: Millions Face Tax Threat. Invesco and State Street Mull Merger
Bloomberg · 5d ago
All Storage Works With CBRE on $1 Billion-Plus Sale
Bloomberg · 6d ago
Dutch Bros, Cathie Wood's Ark (ARKK), Goldman ETF (GTEK): Investment Outlook
Bloomberg · 6d ago
IPO Stocks Break Into Russell Indexes in Biggest Wave in Decade
Bloomberg · 09/17 12:43
David Booth’s Dimensional Flips $8 Billion of Assets Into ETFs
Bloomberg · 09/13 13:38
Cathie Wood’s Ark Grants Itself Power to Buy Canada Bitcoin ETFs
Bloomberg · 09/13 11:08
More
No Data
Learn about the latest financial forecast of IHE. Analyze the recent business situations of iShares US Pharmaceuticals ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-2.3778%
--
1-Week
-0.8453%
--
1-Month
1.9367%
--
3-Month
4.0582%
--
6-Month
12.6868%
--
YTD
3.2634%
--
1-Year
19.5234%
--
3-Year
3.2315%
--
5-Year
1.4765%
--
10-Year
12.4567%
--
Since Inception
10.1687%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
iShares US Pharmaceuticals ETF
Risk
Medium risk
Inception Date
2006-05-01
Benchmark
Dow Jones US Healthcare TR
Advisor Company
iShares
Custodian
State Street Bank & Trust Co
Manager
Team Managed